Subject: Pazoo Licensee Harris Lee Colorado Has Best Month Since September 2015

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Pazoo Licensee Harris Lee Colorado Has Best Month Since September 2015
Hot Stock to WatchHot Stock to Watch

Company: Pazoo, Inc. (Pink Sheets: PZOO)


Price: 0.0005

Change (%): + 0.0002 (66.67)

Volume: 25,242,191

Pazoo Licensee Harris Lee Colorado Has Best Month Since September 2015

FLORHAM PARK, N.J., July 13, 2016 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) Pazoo’s licensee Harris Lee Colorado (HLCO) is proud to announce that it performed the most amount of cannabis laboratory tests out of its Denver facility in the month of June 2016 since September 2015. This number of tests conducted in June 2016 is also the highest it has ever been since HLCO took over management from Front Range Analytics in March of 2016.

Furthermore, Harris Lee Colorado recently received its re-certification for their own potency Standard Operating Procedure from the Colorado Department of Public Health and Environment (CPDHE). Final approval from the Colorado Marijuana Enforcement Division is needed however the Colorado Department of Public Health and Environment stated, in a letter to HLCO dated June 28, 2016, that upon review of the supported plan and documentation submitted by HLCO, the CPDHE recommends HLCO be certified from July 1, 2016 through June 30, 2017 in the potency standards of THC, THCA, CBD, CBDA, and CBN.

David Cunic, CEO of Pazoo states, “We are very proud of this achievement in Colorado. Every month since Harris Lee Colorado has taken over management of the Denver Lab, they have showed this kind of increased volume, and now to the point that it has performed the most amount of tests in June as it has over the past nine months. In addition, we are very pleased to hear that our SOP for potency has been re-certified. We will continue to grow our current operations in Denver and are excited about the future. Every month that we move forward we get closer and closer to break even.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks